A national, multicentre, randomised, controlled, parallel-arms, phase III clinical trial of neoadjuvant FOLFOXIRI and chemoradiotherapy versus neoadjuvant CAPOX/FOLFOX and chemoradiotherapy in patients with high-risk locally advanced rectal cancer: study protocol of the MEND-IT II trial

E. Banken, M. Borg, I. E. G. van Hellemond, S. G. van Ravensteijn, H. M. U. Peulen, A. E. Verrijssen, J. Nederend, A. W. Daniels-Gooszen, T. R. van Oudheusden, G. van Lijnschoten, J. G. Bloemen, H. J. T. Rutten, H. L. van Westreenen, J. W. B. de Groot, C. Verhoef, P. J. Tanis, B. A. Grotenhuis, A. G. J. Aalbers, I. M. Werter, M. D. den Hartogh, J. A. J. Douma, T. G. A. Calon, L. B. J. Valkenburg-van Iersel, G. L. Beets, J. B. Tuynman, M. P. W. Intven, S. M. J. van Kuijk, M. Berbée, T. E. Buffart, J. M. L. Roodhart, J. W. A. Burger, Unknown

Open source

DOI: 10.1186/s12885-026-16072-5
Published: 2026-05-18
Container: BMC Cancer
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12885-026-16072-5,
  title = {A national, multicentre, randomised, controlled, parallel-arms, phase III clinical trial of neoadjuvant FOLFOXIRI and chemoradiotherapy versus neoadjuvant CAPOX/FOLFOX and chemoradiotherapy in patients with high-risk locally advanced rectal cancer: study protocol of the MEND-IT II trial},
  author = {E. Banken and M. Borg and I. E. G. van Hellemond and S. G. van Ravensteijn and H. M. U. Peulen and A. E. Verrijssen and J. Nederend and A. W. Daniels-Gooszen and T. R. van Oudheusden and G. van Lijnschoten and J. G. Bloemen and H. J. T. Rutten and H. L. van Westreenen and J. W. B. de Groot and C. Verhoef and P. J. Tanis and B. A. Grotenhuis and A. G. J. Aalbers and I. M. Werter and M. D. den Hartogh and J. A. J. Douma and T. G. A. Calon and L. B. J. Valkenburg-van Iersel and G. L. Beets and J. B. Tuynman and M. P. W. Intven and S. M. J. van Kuijk and M. Berbée and T. E. Buffart and J. M. L. Roodhart and J. W. A. Burger and Unknown},
  year = {2026},
  journal = {BMC Cancer},
  doi = {10.1186/s12885-026-16072-5},
  url = {https://doi.org/10.1186/s12885-026-16072-5}
}

RIS

TY  - JOUR
TI  - A national, multicentre, randomised, controlled, parallel-arms, phase III clinical trial of neoadjuvant FOLFOXIRI and chemoradiotherapy versus neoadjuvant CAPOX/FOLFOX and chemoradiotherapy in patients with high-risk locally advanced rectal cancer: study protocol of the MEND-IT II trial
AU  - E. Banken
AU  - M. Borg
AU  - I. E. G. van Hellemond
AU  - S. G. van Ravensteijn
AU  - H. M. U. Peulen
AU  - A. E. Verrijssen
AU  - J. Nederend
AU  - A. W. Daniels-Gooszen
AU  - T. R. van Oudheusden
AU  - G. van Lijnschoten
AU  - J. G. Bloemen
AU  - H. J. T. Rutten
AU  - H. L. van Westreenen
AU  - J. W. B. de Groot
AU  - C. Verhoef
AU  - P. J. Tanis
AU  - B. A. Grotenhuis
AU  - A. G. J. Aalbers
AU  - I. M. Werter
AU  - M. D. den Hartogh
AU  - J. A. J. Douma
AU  - T. G. A. Calon
AU  - L. B. J. Valkenburg-van Iersel
AU  - G. L. Beets
AU  - J. B. Tuynman
AU  - M. P. W. Intven
AU  - S. M. J. van Kuijk
AU  - M. Berbée
AU  - T. E. Buffart
AU  - J. M. L. Roodhart
AU  - J. W. A. Burger
AU  - Unknown
PY  - 2026
JO  - BMC Cancer
DO  - 10.1186/s12885-026-16072-5
UR  - https://doi.org/10.1186/s12885-026-16072-5
ER  -

APA

Banken, E., Borg, M., Hellemond, I. E. G. V., Ravensteijn, S. G. V., Peulen, H. M. U., Verrijssen, A. E., Nederend, J., Daniels-Gooszen, A. W., Oudheusden, T. R. V., Lijnschoten, G. V., Bloemen, J. G., Rutten, H. J. T., Westreenen, H. L. V., Groot, J. W. B. D., Verhoef, C., Tanis, P. J., Grotenhuis, B. A., Aalbers, A. G. J., Werter, I. M., Hartogh, M. D. D., Douma, J. A. J., Calon, T. G. A., Iersel, L. B. J. V., Beets, G. L., Tuynman, J. B., Intven, M. P. W., Kuijk, S. M. J. V., Berbée, M., Buffart, T. E., Roodhart, J. M. L., Burger, J. W. A., & Unknown (2026). A national, multicentre, randomised, controlled, parallel-arms, phase III clinical trial of neoadjuvant FOLFOXIRI and chemoradiotherapy versus neoadjuvant CAPOX/FOLFOX and chemoradiotherapy in patients with high-risk locally advanced rectal cancer: study protocol of the MEND-IT II trial. BMC Cancer. https://doi.org/10.1186/s12885-026-16072-5

Source records

crossref · retrieved 2026-09-25T17:30:04.788Z